Bavarian Nordic Appoints Former Sanofi Executive as New CEO

Dow Jones09-17
 
 

Vaccine maker Bavarian Nordic named former Sanofi executive Tarja Stenvall as its next chief executive, replacing longtime boss Paul Chaplin.

The Danish company said Thursday that Stenvall's appointment as CEO would become effective on Oct. 15. She most recently served as head of Sanofi's diabetes and cardiovascular-disease franchises, and previously worked at AstraZeneca and Pfizer.

Bavarian Nordic said in March that Chaplin would step down for personal reasons by the end of the year.

 
 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment